Predictors of health workers decision to test febrile patients for malaria.

<p>HW = health worker.</p>a<p>Only selected variables of programmatic importance are presented.</p

The map of Kenya showing provincial administrative boundaries and position within Africa.

<p>The map of Kenya showing provincial administrative boundaries and position within Africa.</p

Levels and changes in key diagnostic and treatment indicators - performance of the new case-management policy (analysis at all health facilities) and health workers adherence to guidelines (analysis at facilities with available diagnostics and AL).

<p>AL = artemether-lumefantrine; AM = antimalarial; QN = quinine; SP = sulfadoxine-pyrimethamine; AS = artesunate; AQ = amodiaquine; DHA = dihydroartemisinin; ART = artemether.</p>a<p>Defined as management of febrile patient meeting all of the following three criteria: 1) patient tested for malaria; 2) if positive test result treated with AL, and 3) if negative test not treated for malaria.</p>b<p>Denominators in this category include 295 patients at baseline and 212 at follow-up surveys.</p>c<p>Denominators in this category include 280 patients at baseline and 238 at follow-up surveys.</p>d<p>Other antimalarial treatment include QN (18), SP (3), AS+AQ (2), DHA (2), QN+SP (2), ART (1) and AL+SP (1).</p>e<p>Other antimalarial treatment include AL+QN (8), QN (6), AQ (3) and AL+SP (1).</p>f<p>Other antimalarial treatment include AL+QN (28), SP (28), QN (14), AQ (4) and DHA (1).</p

Levels and changes in health facility and health worker readiness to implement new case-management policy.

<p>RDT = rapid diagnostic test; AL = artemether-lumefantrine; CM = case management; NA = not applicable.</p>a<p>Denominator does not include 1 health facility with missing value.</p>b<p>Denominator does not include 2 health facilities with missing values.</p